Home › Compare › RNVAW vs EQR

RNVAW vs EQR: Dividend Comparison 2026

RNVAW yields 23668.64% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RNVAW wins by $279577175103618252800.00M in total portfolio value
10 years
RNVAW
RNVAW
● Live price
23668.64%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$279577175103618252800.00M
Annual income
$277,272,702,204,883,170,000,000,000.00
Full RNVAW calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — RNVAW vs EQR

📍 RNVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNVAWEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNVAW + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RNVAW pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNVAW
Annual income on $10K today (after 15% tax)
$2,011,834.32/yr
After 10yr DRIP, annual income (after tax)
$235,681,796,874,150,700,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, RNVAW beats the other by $235,681,796,874,150,700,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNVAW + EQR for your $10,000?

RNVAW: 50%EQR: 50%
100% EQR50/50100% RNVAW
Portfolio after 10yr
$139788587551809126400.00M
Annual income
$138,636,351,102,441,580,000,000,000.00/yr
Blended yield
99.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

RNVAW
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNVAW buys
0
EQR buys
0
No recent congressional trades found for RNVAW or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNVAWEQR
Forward yield23668.64% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$279577175103618252800.00M ✓$47.8K
Annual income after 10y$277,272,702,204,883,170,000,000,000.00 ✓$5,475.61
Total dividends collected$279425321851775516672.00M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RNVAW vs EQR ($10,000, DRIP)

YearRNVAW PortfolioRNVAW Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$2,377,564$2,366,863.91$11,380$679.82+$2.37M → RNVAW
2$528,466,441$525,922,447.67$13,014$837.25+$528.45M → RNVAW
3$109,815,886,597$109,250,427,505.03$14,961$1,036.20+$109815.87M → RNVAW
4$21,334,656,863,270$21,217,153,864,611.61$17,297$1,289.22+$21334656.85M → RNVAW
5$3,875,161,235,900,700$3,852,333,153,056,999.50$20,121$1,613.15+$3875161235.88M → RNVAW
6$658,095,867,366,922,600$653,949,444,844,508,900.00$23,561$2,030.84+$658095867366.90M → RNVAW
7$104,495,183,582,989,550,000$103,791,021,004,906,940,000.00$27,783$2,573.54+$104495183582989.52M → RNVAW
8$15,514,022,533,886,978,000,000$15,402,212,687,453,182,000,000.00$33,013$3,284.39+$15514022533886978.00M → RNVAW
9$2,153,712,989,472,060,400,000,000$2,137,112,985,360,801,400,000,000.00$39,547$4,223.51+$2153712989472060416.00M → RNVAW
10$279,577,175,103,618,260,000,000,000$277,272,702,204,883,170,000,000,000.00$47,791$5,475.61+$279577175103618252800.00M → RNVAW

RNVAW vs EQR: Complete Analysis 2026

RNVAW — Stock

Rennova Health, Inc., together with its subsidiaries, engages in the hospital operations in the United States. It operates in two segments, Hospital Operations and Clinical Laboratory Services. The company provides a suite of healthcare related products and services for healthcare providers, patients, and individuals. It also offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. In addition, the company provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Further, it invests in and develops a suite of software products to its diagnostics business. Additionally, the company owns three hospitals, a physician's office in Tennessee, and a rural clinic in Kentucky. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.

Full RNVAW Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this RNVAW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNVAW vs SCHDRNVAW vs JEPIRNVAW vs ORNVAW vs KORNVAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.